These Regulations amend two sets of Regulations which make provision about, and in connection with, pharmaceutical services.

Regulation 2 amends the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 and regulation 3 amends the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024.

The Welsh Ministers’ Code of Practice on the carrying out of Regulatory Impact Assessments was considered in relation to these Regulations. As a result, it was not considered necessary to carry out a regulatory impact assessment as to the likely costs and benefits of complying with these Regulations.